AATec Medical GmbH | Finanzwire

BRIEF

published on 09/18/2024 at 10:05, 3 months 3 days ago

AATec Medical Welcomes Professor James Chalmers to Scientific Advisory Board

Scientific Advisory Board AATec Medical James Chalmers Bronchiectasis Recombinant AAT
PRESS RELEASE

published on 09/18/2024 at 10:00, 3 months 3 days ago

AATec Medical Welcomes Professor James Chalmers to Scientific Advisory Board
AATec Medical welcomes Professor James Chalmers, a renowned expert in respiratory medicine, to its Scientific Advisory Board to advance product development in non-CF bronchiectasis

Scientific Advisory Board AATec Medical Professor James Chalmers Respiratory Medicine Non-CF Bronchiectasis
BRIEF

published on 07/24/2024 at 10:05, 4 months 28 days ago

AATec Medical Makes Significant Strides in First Year of Operations

Biotechnology Clinical Trials AATec Medical ATL-105 Inflammatory Lung Diseases
PRESS RELEASE

published on 07/24/2024 at 10:00, 4 months 28 days ago

AATec Medical reports significant progress in company’s first year towards unlocking the therapeutic potential of AAT
AATec Medical reports significant progress in unlocking therapeutic potential of AAT for treating inflammatory lung diseases in its first year. Company advances lead candidate ATL-105 for NCFB

AATec Medical ATL-105 Inflammatory Lung Diseases Therapeutic Potential NCFB
BRIEF

published on 02/29/2024 at 09:30, 9 months 21 days ago

AATec Medical enriches its Scientific Council with the arrival of Professor Claus Franz Vogelmeier

AATec Medical Professor Claus Franz Vogelmeier Inflammatory Lung Diseases Scientific Council Alpha-1 Antitrypsin
PRESS RELEASE

published on 02/29/2024 at 09:30, 9 months 21 days ago

AATec Medical appoints Professor Dr. Claus Franz Vogelmeier to the Scientific Advisory Board
AATec Medical appoints Prof. Dr. Claus Franz Vogelmeier, a renowned pulmonology expert, to its Scientific Advisory Board, enhancing expertise in inflammatory lung diseases. Visit www.aatec-medical.com for details

Scientific Advisory Board AATec Medical Inflammatory Lung Diseases Alpha-1 Antitrypsin Professor Dr. Claus Franz Vogelmeier
PRESS RELEASE

published on 02/06/2024 at 09:00, 10 months 15 days ago

AATec Medical starts collaboration with the German Federal Agency for Disruptive Innovation SPRIND for alpha-1 antitrypsin
AATec Medical collaborates with German Federal Agency for Disruptive Innovation SPRIND to develop ATL-105, a recombinant alpha-1 antitrypsin platform for respiratory diseases, including viral infections and inflammatory diseases

Respiratory Diseases AATec Medical German Federal Agency For Disruptive Innovation SPRIND ATL-105 Recombinant Alpha-1 Antitrypsin
PRESS RELEASE

published on 10/31/2023 at 10:00, 1 year 1 month ago

AATec Medical and Beurer enter development collaboration for inhaled Alpha-1 Antitrypsin
PRESS RELEASE

published on 10/10/2023 at 11:00, 1 year 2 months ago

AATec Medical GmbH: AATec Medical Announces Creation of Scientific Advisory Board
PRESS RELEASE

published on 07/17/2023 at 11:00, 1 year 5 months ago

AATec Medical GmbH: AATec Medical Announces its Launch with EUR 2.7 million in Seed Financing to Unlock the Therapeutic Potential of Alpha-1 Antitrypsin

Published on 12/21/2024 at 01:30, 12 hours 4 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 12 hours 4 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 13 hours 29 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 13 hours 34 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 14 hours 4 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 12 hours 43 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 12 hours 49 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 18 hours 24 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 18 hours 38 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 19 hours 34 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 1 hour 16 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 19 hours 34 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 19 hours 39 minutes ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 23 hours 34 minutes ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 1 day 19 hours ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE

News